Sol and Clara Kest Professor and Chairman
Department of Dermatology
The Mount Sinai School of Medicine
New York, NY
Dr. Lebwohl is Professor and Chairman of the Department of Dermatology at The Mount Sinai School of Medicine, having served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl has served as chairman of the Psoriasis Task Force of the American Academy of Dermatology and as chairman of the Scientific Assembly Council.
Dr. Lebwohl is chairman of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as medical editor of The Bulletin of the National Psoriasis Foundation, Psoriasis Advance. He is on the editorial board editor of the Journal of the American Academy of Dermatology, and editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine. Dr. Lebwohl is a current Program Director of The Johns Hopkins eLiterature Review program eMedicalDermatology Review. He has written/edited several books and authored or co-authored over 400 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.
Mark Lebwohl, MD has disclosed that he has received grants for clinical research from Can-Fite Biopharma and Clinuvel. He also disclosed that he has worked as a consultant for and receiving honorarium from Abgenomics, Allos, Amgen, Astellas, DermaGenoma, DermiPsor, Ethicon, Genentech, GlaxoSmithKline-Stiefel, Glenmark Pharmaceuticals, HelixBioMedix, Janssen Ortho Biotech, LEO Pharmaceuticals, Novartis, Nycomed, Onset Therapeutics, Pfizer, Valeant Pharmaceuticals.